Hybrid Capture II (HC-II) is a commercial human papillomavirus (HPV) detection test designed to detect 18 HPV types divided into high-risk and low-risk groups. We have tested 1647 scrapes from 1518 unselected women attending routine cytological screening by this assay for the detection of histologically proven high-grade lesions. The reliability of this test was also evaluated on 117 fresh cone biopsy samples. HPV DNA has been detected in 400 scrapes (24.3%), 296 containing a high-risk HPV (18.0%). All the smears evocative of high-grade lesions were positive for high-risk HPV, and high-risk HPV were detected in all the 34 cases presenting a histologically proven high-grade lesion and in 68 (97.1%) of the 70 cone biopsy samples showing a high-grade lesion or an invasive carcinoma. Thus, the sensitivity was superior to the sensitivity of cytology (85.3%). Nevertheless, the quantitative approach provided by the HC-II assay for the assessment of the viral load could not clearly distinguish among cases with or without high-grade lesions. Thus this assay is recommended for the screening of high-grade lesions on a large scale, in association with classic cytology.
Bosch, F. X., Manos, M. M., Munoz, N., Sherman, M., Jansen, A. M., Peto, J., Schiffman, M. H., Moreno, V., Kurman, R. & Shah, K. V. International Biological Study in Cervical Cancer Study Group (1995). Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 87: 796–802.
Clavel, C., Bory, J. P., Rihet, S., Masure, M., Duval-Binninger, I., Putaud, I., Lorenzato, M., Quereux, C. & Birembaut, P. (1998a). Comparative analysis of the human papillomavirus detection by Hybrid Capture assay and routine cytology screening to detect high grade cervical lesions. Int J Cancer 75: 525–528.
Clavel, C., Masure, M., Putaud, I., Thomas, K., Lorenzato, M., Bory, J. P., Gabriel, R., Quereux, C. & Birembaut, P. (1998b). Hybrid Capture II, a new sensitive test for human papillomavirus detection. Comparison with Hybrid Capture I and PCR results in cervical lesions. J Clin Pathol 51: 737–740.
Cole, H. M. (1993). Human papillomavirus DNA testing in the management of cervical neoplasia. JAMA 270: 2975–2981.
Cox, J. T., Lorincz, A. T., Schiffman, M. H., Sherman, M. E., Cullen, A. & Kurman, R. J. (1995). Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 172: 946–954.
Cuzick, J., Terry, G., Ho, L., Hollingworth, T. & Anderson, M. (1994). Human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia. Brit J Cancer 69: 167–171.
Farthing, A., Masterson, P., Mason, W. P. & Vousden, K. H. (1995). Human papillomavirus detection by hybrid capture and its possible clinical use. J Clin Pathol 47: 649–652.
Gaarenstroom, K. N., Melkert, P., Walboomers, J. M. M., Van den Brule, A. J. C., Van Bommel, P. F. J., Meijer, CJLM, Voorhorst, F. J., Kenemans, P. & Helmerhorst, T. J. M. (1994). Human papillomavirus DNA genotypes: prognostic factors for progression of cervical intraepithelial neoplasia. Int J Gynecol Cancer 4: 73–78.
Hatch, K. D., Schneider, A. & Addel-Nour, M. W. (1995). An evaluation of human papillomavirus testing for intermediate- and high-risk types as triage before colposcopy. Am J Obstet Gynecol 172: 1150–1157.
Ho, G. Y. F., Burk, R. D., Klein, S., Kadish, A. S., Chang, C. J., Palan, P., Basu, J., Tachzy, R., Lewis, R. & Romney, S. (1995). Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 187: 1365–1371.
Kaufman, R. H., Adam, E., Icenogle, J., Lawson, H., Lee, N., Reeves, K. O., Irwin, J., Simon, T., Press, M., Uhler, R., Entman, C. & Reeves, W. C. (1997). Relevance of human papillomavirus screening in management of cervical intraepithelial neoplasia. Am J Obstet Gynecol 176: 87–92.
Koutsky, L. A., Holmes, K. K., Critchlow, C. W., Stevens, C. E., Paavonen, J., Beckmann, A. M., Derouen, T. A., Galloway, D. A., Vernon, D. & Kiviat, N. B. (1992). A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 327: 1272–1278.
Lorincz, A. T. (1996). Hybrid Capture method for detection of human papillomavirus DNA in clinical specimens. Papillomavirus Rep 7: 1–5.
Lorincz, A. T., Reid, R., Jenson, A. B., Greenberg, M. D., Lancaster, W. & Kurman, R. J. (1992). Human papillomavirus infection of the cervix: relative risk association of 15 common anogenital types. Obstet Gynecol 79: 328–337.
Remmink, A. J., Walboomers, J. M. M., Helmerhorst, T. J. M., Voorhorst, F. J., Rozendal, L., Risse, E. K. J., Meijer, CJLM & Kenemans, P. (1995). The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer 61: 306–311.
Richart, R. M. & Wright, T. C. (1993). Controversies in the management of low grade cervical intraepithelial neoplasia. Cancer 71: 1413–1421.
Rozendaal, L., Walboomers, J. M. M., Van Der Linden, J. C., Voorhorst, F. J., Kenemans, P., Helmerhorst, T. J. M., Van Ballegooijen, M. & Meijer, CJLM (1996). PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears. Int J Cancer 68: 766–769.
Schiffman, M. H., Kiviat, N. B., Burk, R. D., Shah, K. V., Daniel, R. W., Lewis, R., Kuypers, J., Manos, M. M., Scott, D. R., Sherman, M. E., Kurman, R. J., Stoler, M. H., Glass, A. G., Rush, B. B., Mielzinska, I. & Lorincz, A. T. (1995). Accuracy and interlaboratory reliability of human papillomavirus DNA testing by Hybrid Capture. J Clin Microbiol 33: 545–550.
Sun, X. W., Ferenczy, A., Johnson, D., Koulos, J. P., Jungu, O., Richart, R. M. & Wright, T. C. Jr (1995). Evaluation of the Hybrid Capture human papillomavirus deoxyribonucleic acid detection test. Am J Obstet Gynecol 173: 1432–1437.
Van Den Brule, A. J. C., Walboomers, J. M. M., Du Maine, M., Kenemans, P. & Meijer, CJLM (1991). Difference in prevalence of human papillomavirus genotypes in cytomorphologically normal smears is associated with a history of cervical intraepithelial neoplasia. Int J Cancer 48: 404–408.
Walboomers, J. M. M., De Roda Husman, A. M., Snijders, P. J. F., Stel, H. V., Risse, E. K. J., Helmelhorst, T. J. M., Voorhorst, F. J. & Meijer, CJLM (1994). Detection of genital human papillomavirus infections. Critical review of methods and prevalence studies in relation to cervical cancer. In: Human Papillomavirus and Cervical Cancer. Biology and Immunology, Stern PL Stanley MA (eds), pp. 41–71. Oxford University Press: Oxford:
Wright, T. C. Jr, Lorincz, A. T., Ferris, D. G., Richart, R. M., Ferenczy, A., Mielsynska, I. & Borgatta, L. (1998). Reflex human papillomavirus deoxyribonucleic acid testing in women with abnormal Papanicolaou smears. Am J Obstet Gynecol 178: 962–966.
Zur Hausen, H. (1994). Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr Top Microbiol Immunol 186: 131–156.
About this article
Cite this article
Clavel, C., Masure, M., Bory, JP. et al. Hybrid Capture II-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 1518 women. Br J Cancer 80, 1306–1311 (1999). https://doi.org/10.1038/sj.bjc.6690523
- human papillomavirus
- cervical cancer
- cytological screening
A global epidemic increase of an HPV‐induced tonsil and tongue base cancer – potential benefit from a pan‐gender use of HPV vaccine
Journal of Internal Medicine (2020)
The Laryngoscope (2020)
Mouthwash-Based Highly Sensitive Pyro-Genotyping for Nine Sexually Transmitted Human Papilloma Virus Genotypes
International Journal of Molecular Sciences (2020)
HPV ‐based cervical cancer screening in low‐resource settings: Maximizing the efficiency of community‐based strategies in rural Kenya
International Journal of Gynecology & Obstetrics (2020)
Gardasil Vaccination for Recurrent Laryngeal Papillomatosis in Adult Men Second Report: Negative Conversion of HPV in Laryngeal Secretions
Journal of Voice (2018)